Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Publication year range
1.
J Pain Palliat Care Pharmacother ; 23(3): 261-81, 2009.
Article in English | MEDLINE | ID: mdl-19670022

ABSTRACT

These consensus guidelines have been developed by a group of Latin American experts in pain management, to point out patterns and make practical recommendations to guide the diagnosis, identify warning signs (yellow and red flags), and establish comprehensive medical management (pharmacologic and nonpharmacologic treatment) and monitoring plans for patients enduring neuropathic pain. From the viewpoint of pharmacologic management, drugs are classified into groups according to efficacy, availability/accessibility, and safety criteria. Drugs are recommended for use depending on the disease and particular circumstances of each patient, with an approach that favors multimodal treatment while taking into consideration the idiosyncrasies of medical practice in Latin America.


Subject(s)
Analgesics/therapeutic use , Neuralgia/drug therapy , Analgesics/adverse effects , Analgesics/pharmacology , Humans , Latin America , Neuralgia/diagnosis , Neuralgia/etiology , Pain Measurement , Practice Guidelines as Topic
2.
Arch. venez. farmacol. ter ; 28(1): 2-11, ene. 2009. ilus, tab
Article in Spanish | LILACS | ID: lil-630347

ABSTRACT

El dolor neuropático es un síndrome de muy difícil manejo en la práctica clínica. Suele originarse a consecuencia de lesiones o enfermedades que afectan al sistema somatosensorial. Lesiones de nervios periféricos, la diabetes, el virus herpes zoster, entre otras, son ejemplos de entidades clínicas que causan dolor neuropático. Este tipo de dolor supone modificaciones de la fisiología normal de las neuronas que integran la vía de transmisión nociceptiva y que operan tanto a nivel periférico, como central. Entre estos mecanismos se incluye la generación de descargas ectópicas, cambios en el genoma de las neuronas involucradas, alteración de canales iónicos, pérdida de las actividades inhibitorias endógenas, activación anormal del sistema inmunitario y sensibilización tanto periférica, como central. Este artículo resume los mecanismos moleculares y neuroplásticos que ocurren en situaciones de dolor neuropático y revisa diferentes modelos experimentales para su estudio. El desarrollo de estos modelos ha permitido dilucidar los mecanismos subyacentes de esta patología, el diseño de nuevas estrategias terapéuticas y el diagnóstico acertado de la enfermedad


Neuropathic pain is a very complex clinical syndrome that results as a consequence of lesions or diseases affecting the somatosensory system. Lesion of peripheral nerves, diabetes, herpes zoster virus, among others, are clinical entities that may cause neuropathic pain. Neuropathic pain also reflects changes of the normal physiology of the nociceptive transmission neurons that may happen at peripheral and central levels. These mechanisms include the generation of ectopic discharges, genomic changes of the neurons involved, alterations of ionic channels and of the endogenous inhibition of pain, abnormal activation of the immune system as well as peripheral and central sensitization. This article review the molecular and neuroplastic mechanisms associated to neuropathic pain and discuss different experimental models for its study. The development of these models has been helpful to understand the subjacent mechanisms of this pathology, and has contributed to design new therapeutical approaches and the correct diagnose of the disease


Subject(s)
Female , Inflammation , Pain Management , Pain Measurement , Analgesics/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL